184 related articles for article (PubMed ID: 36583943)
1. Carborane Analogues of Fenoprofen Exhibit Improved Antitumor Activity.
Useini L; Mojić M; Laube M; Lönnecke P; Mijatović S; Maksimović-Ivanić D; Pietzsch J; Hey-Hawkins E
ChemMedChem; 2023 Mar; 18(5):e202200583. PubMed ID: 36583943
[TBL] [Abstract][Full Text] [Related]
2. Carborane Conjugates with Ibuprofen, Fenoprofen and Flurbiprofen: Synthesis, Characterization, COX Inhibition Potential and In Vitro Activity.
Sonam S; Jelača S; Laube M; Schädlich J; Pietzsch J; Maksimović-Ivanić D; Mijatović S; Kaluđerović GN; Hey-Hawkins E
ChemMedChem; 2024 Jun; ():e202400018. PubMed ID: 38844420
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of transthyretin amyloidosis inhibitors containing carborane pharmacophores.
Julius RL; Farha OK; Chiang J; Perry LJ; Hawthorne MF
Proc Natl Acad Sci U S A; 2007 Mar; 104(12):4808-13. PubMed ID: 17360344
[TBL] [Abstract][Full Text] [Related]
4. Carboranyl Analogues of Mefenamic Acid and Their Biological Evaluation.
Useini L; Mojić M; Laube M; Lönnecke P; Dahme J; Sárosi MB; Mijatović S; Maksimović-Ivanić D; Pietzsch J; Hey-Hawkins E
ACS Omega; 2022 Jul; 7(28):24282-24291. PubMed ID: 35874202
[TBL] [Abstract][Full Text] [Related]
5. Fenoprofen: a review of its pharmacological properties and therapeutic efficacy in rheumatic diseases.
Brogden RN; Pinder RM; Speight TM; Avery GS
Drugs; 1977 Apr; 13(4):241-65. PubMed ID: 324748
[TBL] [Abstract][Full Text] [Related]
6. Carborane-Based Tebufelone Analogs and Their Biological Evaluation In Vitro.
Braun S; Paskaš S; Laube M; George S; Hofmann B; Lönnecke P; Steinhilber D; Pietzsch J; Mijatović S; Maksimović-Ivanić D; Hey-Hawkins E
ChemMedChem; 2023 Jul; 18(14):e202300206. PubMed ID: 37160667
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of action of aspirin-like drugs.
Vane JR; Botting RM
Semin Arthritis Rheum; 1997 Jun; 26(6 Suppl 1):2-10. PubMed ID: 9219313
[TBL] [Abstract][Full Text] [Related]
8. Dual acting anti-inflammatory drugs: a reappraisal.
Bertolini A; Ottani A; Sandrini M
Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
[TBL] [Abstract][Full Text] [Related]
9. COX-2 specific inhibitors offer improved advantages over traditional NSAIDs.
Urban MK
Orthopedics; 2000 Jul; 23(7 Suppl):S761-4. PubMed ID: 10914695
[TBL] [Abstract][Full Text] [Related]
10. Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond.
Rao P; Knaus EE
J Pharm Pharm Sci; 2008 Sep; 11(2):81s-110s. PubMed ID: 19203472
[TBL] [Abstract][Full Text] [Related]
11. [Non-steroidal anti-inflammatory agents with selective inhibitory activity on cyclooxygenase-2. Interest and future prospects].
Blain H; Jouzeau JY; Netter P; Jeandel C
Rev Med Interne; 2000 Nov; 21(11):978-88. PubMed ID: 11109595
[TBL] [Abstract][Full Text] [Related]
12. [Preferential COX-2 inhibition: its clinical relevance for gastrointestinal non-steroidal anti-inflammatory rheumatic drug toxicity].
Dammann HG
Z Gastroenterol; 1999 Jan; 37(1):45-58. PubMed ID: 10091284
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays.
Riendeau D; Charleson S; Cromlish W; Mancini JA; Wong E; Guay J
Can J Physiol Pharmacol; 1997 Sep; 75(9):1088-95. PubMed ID: 9365818
[TBL] [Abstract][Full Text] [Related]
14. New drugs for the treatment of rheumatoid arthritis.
Schuna AA; Megeff C
Am J Health Syst Pharm; 2000 Feb; 57(3):225-34. PubMed ID: 10674776
[TBL] [Abstract][Full Text] [Related]
15. Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis).
Kroon FP; van der Burg LR; Ramiro S; Landewé RB; Buchbinder R; Falzon L; van der Heijde D
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD010952. PubMed ID: 26186173
[TBL] [Abstract][Full Text] [Related]
16. [The role of cyclooxygenase and prostaglandins in the pathogenesis of rheumatoid arthritis].
Stańczyk J; Kowalski ML
Pol Merkur Lekarski; 2001 Nov; 11(65):438-43. PubMed ID: 11852819
[TBL] [Abstract][Full Text] [Related]
17. [Case report: reversible acute renal failure following therapy with both ketorolac (non-selective non-steroidal anti-inflammatory drug NSAID) and celecoxib (COX-2 selective) in the same patient].
Galli G; Panzetta G
G Ital Nefrol; 2002; 19(2):199-203. PubMed ID: 12195419
[TBL] [Abstract][Full Text] [Related]
18. COX-2 selective inhibitors in the treatment of arthritis: a rheumatologist perspective.
Hochberg MC
Curr Top Med Chem; 2005; 5(5):443-8. PubMed ID: 15974939
[TBL] [Abstract][Full Text] [Related]
19. Epidemiological and clinical aspects of nonsteroidal anti-inflammatory drugs and cancer risks.
Moran EM
J Environ Pathol Toxicol Oncol; 2002; 21(2):193-201. PubMed ID: 12086406
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory drugs in the 21st century.
Rainsford KD
Subcell Biochem; 2007; 42():3-27. PubMed ID: 17612044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
